# Commit Biologics **Source:** https://www.startuphub.ai/startups/commit-biologics **Profile type:** Startup > Developer of complement-powered immune engagers for cancer and autoimmune diseases. ## About Commit Biologics is a Danish biotechnology company developing a new class of immunotherapy treatments for cancer and autoimmune diseases. Using its proprietary Bispecific Complement Engager (BiCE) platform, the company designs complement-powered immune engagers that selectively eliminate diseased cells through complement activation without relying on T cells. ## Key facts - **Slug:** commit-biologics - **Website:** https://commitbio.com - **Location:** Copenhagen, Denmark - **Founded:** 2021-01-01 - **Operating status:** Active - **Total funding:** $77M - **Sectors / tags:** Biotech, Immunotherapy, Oncology ## StartupHub.ai scores - **Ahrefs DR:** 6/100 - **Agent Readiness:** D (57/100) - **Site Speed:** 66/100 - **Data Trust:** 62/100 ## Funding rounds | Date | Round | Amount | Lead investors | | --- | --- | --- | --- | | 1 Nov 2026 | [Seed](https://www.startuphub.ai/investment_rounds/commit-biologics-seed-2026) | $60M | - | | 22 Aug 2024 | [Seed](https://www.startuphub.ai/investment_rounds/commit-biologics-seed-2024) | $17.3M | [Bioqube Ventures](https://www.startuphub.ai/investors/bioqube-ventures), [Novo Holdings](https://www.startuphub.ai/investors/novo-holdings) | ## Tech stack Detected on commitbio.com, last scanned 2026-11-17. - **Frontend:** jQuery - **SEO:** Yoast SEO - **CMS / Builders:** WordPress - **Email provider:** Barracuda ## JSON-LD Structured data aligned with this page's `